Close-up of stethoscope on desk with doctor's hands out of focus in background typing on a laptop.
Our Work

Latham Advises Quadria Capital-Led Consortium on Take-Private of Apex Healthcare

February 27, 2026
Transaction represents the largest healthcare privatization in Southeast Asia in the past five years and in Malaysia’s history.

Latham & Watkins has advised a consortium led by Quadria Capital, one of Asia’s largest healthcare-focused private equity firms, on the acquisition of Apex Healthcare Berhad (Apex), taking the company private in a transaction valued at an implied market capitalisation of approximately MYR 1.9 billion (US$470 million), based on the offer price of MYR 2.64 per share.

Following the completion of the acquisition and delisting, Apex will be 100% privately owned by a consortium led by Quadria Capital together with co-investors 65 Equity Partners, Employees Provident Fund, and Silk Road Fund.

The Latham team was led by Singapore partner Marcus Lee, with associates Elena Yeung and Cher Lin Chin. Advice was also provided on finance matters by Singapore partner Chuan Wei Kong and on antitrust matters by London partner Stephanie Adams.

Endnotes

    Contacts

    Lee, Marcus

    Marcus Lee

    Singapore
    marcus.lee@lw.com +65.6437.5452